-+ 0.00%
-+ 0.00%
-+ 0.00%

CAN FITE BIOPHARMA - INTERIM ANALYSIS RESULTS FOR PHASE III PICLIDENOSON STUDY EXPECTED Q1 2027

Reuters·11/18/2026 12:00:04

Please log in to view news